Malignant Brain Neoplasm — Trials

Malignant Brain Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

636 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (99)

clinicaltrialsPublishedShowing 251–253 of 253 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00553748	Phase I, Open Label, Single Center Safety Study of [F-18]FLT	completed	Phase 1	11	Siemens Molecular ImagingINDUSTRY	1	Jul 3, 2008	clinicaltrials
NCT00001502	A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Mar 4, 2008	clinicaltrials
NCT00505141